Corcept Therapeutics Incorporated
CORT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $141,209 | $106,140 | $101,418 | $112,512 |
| Dep. & Amort. | $1,336 | $2,362 | $3,446 | $3,067 |
| Deferred Tax | -$40,191 | -$29,493 | -$33,905 | $4,346 |
| Stock-Based Comp. | $61,354 | $48,940 | $42,442 | $42,931 |
| Change in WC | $45,297 | $8,218 | $5,539 | -$57 |
| Other Non-Cash | -$10,938 | -$9,128 | $1,383 | $5,093 |
| Operating Cash Flow | $198,067 | $127,039 | $120,323 | $167,892 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2,172 | -$139 | -$413 | -$469 |
| Net Acquisitions | $0 | $0 | $0 | -$136,595 |
| Inv. Purchases | -$588,310 | -$328,748 | -$355,066 | -$312,805 |
| Inv. Sales/Matur. | $412,878 | $419,793 | $241,152 | $449,400 |
| Other Inv. Act. | $0 | $0 | $0 | $136,595 |
| Investing Cash Flow | -$177,604 | $90,906 | -$114,327 | $136,126 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $9,616 | $0 | $0 | $0 |
| Stock Repurch. | -$15,664 | -$145,428 | $0 | -$295,985 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$22,301 | -$3,295 | -$17,284 | -$6,606 |
| Financing Cash Flow | -$28,349 | -$148,723 | -$17,284 | -$302,591 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$7,886 | $69,222 | -$11,288 | $1,427 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $135,551 | $66,329 | $77,617 | $76,190 |
| End Cash | $127,665 | $135,551 | $66,329 | $77,617 |
| Free Cash Flow | $195,895 | $126,900 | $119,910 | $167,423 |